Seth Feuerstein
Seth Feuerstein, MD, JD is a widely recognized leader in digital therapeutics and healthcare innovation. He has played key roles in developing multiple successful digital health companies. He served as Chief Innovation Officer at Magellan where he oversaw build, study and installation of digital CBT, screening and related software into service offerings to more than 50-million lives and several clinical settings. He assumed this role at Magellan after Cobalt, a digital therapeutics company he founded/ran was acquired by Magellan.
He is also the co-founder of NELS, a CRO that serves several successful biotechnology firms, is an advisor and board member at several health and technology firms and has been in front of the FDA on multiple products including “digital therapeutics”. He sits on the Advisory Board of the Connecticut Bioscience Investment Fund and is on the faculty at the Yale Medical School and is founder and Director of Yale Center for Digital Health and the Principal Investigator on a NIH/NIDA program called “Innovation to Impact” to train researchers to bring research based innovations to the market.
